Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4774885 | 1.00 | TSHR (0.40) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL14270566 | 1.00 | TSHR (0.40) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL5711705 | 1.00 | TSHR (0.40) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL1915388 | 1.00 | TSHR (0.40) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL11926993 | 1.00 | TSHR (0.40) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL1959828 | 1.00 | TSHR (0.40) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL727830 | 1.00 | TSHR (0.40) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL20477180 | 1.00 | TSHR (0.40) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL21114738 | 1.00 | TSHR (0.40) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL29766725 | 1.00 | TSHR (0.40) | TSHRTHRBLMNADNM1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1898 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12629328-B2 | Oil dispersion solid cosmetic composition containing ascorbic acid and preparation method therefor | COSMAX, INC. (KR) | 2026-05-19 | — | — | US | claimed |
| EP-4734912-A2 | HIGH SEPARATION DUAL PHASE EYE MAKE-UP REMOVER | Mary Kay, Inc. (US) | 2026-05-06 | — | — | EP | claimed |
| EP-4734951-A1 | COMPOSITION FOR CONDITIONING THE HAIR | L'OREAL (FR) | 2026-05-06 | — | — | EP | claimed |
| US-20260083657-A1 | COMPOSITION WITH WHITENING EFFECT AND APPLICATION THEREOF IN COSMETICS | YUNNAN BOTANEE BIO-TECHNOLOGY GROUP CO., LTD. (CN) | 2026-03-26 | — | — | US | claimed |
| US-20260083659-A1 | SUNSCREEN COMPOSITIONS AND METHODS OF USE | MARY KAY INC. (US) | 2026-03-26 | — | — | US | claimed |
| EP-4714430-A1 | COSMETIC | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-03-25 | — | — | EP | claimed |
| US-20260069552-A1 | Methods of Providing a Cooling Sensation to Skin Afflicted with Eczema | KENVUE BRANDS LLC (US) | 2026-03-12 | — | — | US | claimed |
| US-12569533-B2 | Bruising and filler compositions and methods for use | ALASTIN Skincare, Inc. (US) | 2026-03-10 | — | — | US | claimed |
| US-20260053760-A1 | Compositions Suitable for Use on Skin Afflicted with Eczema | KENVUE BRANDS LLC (US) | 2026-02-26 | — | — | US | claimed |
| EP-4688908-A2 | CROSSLINKED POLYESTER ELASTOMERS, COMPOSITIONS, AND METHODS OF PREPARATION THEREOF | Momentive Performance Materials Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| EP-1620068-A1 | COSMETIC COMPOSITION COMPRISING A VOLATILE FATTY PHASE | L'OREAL (FR) | 2006-02-01 | — | — | EP | claimed |
| US-20050215072-A1 | Method and system for treating a dielectric film | TOKYO ELECTRON LIMITED (JP) | 2005-09-29 | — | — | US | claimed |
| WO-2004087077-A1 | COSMETIC COMPOSITION COMPRISING A VOLATILE FATTY PHASE | L'OREAL (FR) | 2004-10-14 | — | — | WO | claimed |
| US-20040197284-A1 | Cosmetic composition comprising a volatile fatty phase | L'OREAL S.A. (FR) | 2004-10-07 | — | — | US | claimed |
| EP-1219289-A2 | Cosmetic compositions containing silicone gel | Clariant Life Science Molecules (Florida) Inc. (US) | 2002-07-03 | — | — | EP | claimed |
| US-6355724-B1 | Cosmetic compositions containing silicone gel | CLARIANT LSM (FLORIDA), INC. | 2002-03-12 | — | — | US | claimed |
| US-6258365-B1 | SILICONE-HYDROCARBON HYBRID FLUID COMPROSING TRISILOXANE OR TRIS(SILOXY)SILANE COMPOUND; COSMETICS FOR DRY SKIN TREATMENT | ARCHIMICA (FLORIDA), INC. | 2001-07-10 | — | — | US | claimed |
| US-6036967-A | Mixtures of trimethylsilylated silicas and alkylsiloxanes | ARCHIMICA (FLORIDA), INC. (US) | 2000-03-14 | — | — | US | claimed |
| US-5468417-A | Silicone containing VOC complaint paint remover | DOW CORNING CORPORATION (US) | 1995-11-21 | — | — | US | claimed |
| EP-0657157-A1 | Styling aid containing a volatile alkylmethylsilicone | DOW CORNING CORPORATION (US) | 1995-06-14 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12569533-B2 | Bruising and filler compositions and methods for use | MYADM, COL14A1, HBG1 | TSHR 1278/4885THRB 1333/4885LMNA 358/4885 |
| US-20260069552-A1 | Methods of Providing a Cooling Sensation to Skin Afflicted with Eczema | CUTA, IDO1, CYP8B1 | TSHR 4321/4885THRB 3615/4885LMNA 4693/4885 |
| US-20260083657-A1 | COMPOSITION WITH WHITENING EFFECT AND APPLICATION THEREOF IN COSMETICS | TYR, NQO1, NAMPT | TSHR 2773/4885THRB 3389/4885LMNA 4035/4885 |
| US-12629328-B2 | Oil dispersion solid cosmetic composition containing ascorbic acid and preparation method therefor | DAGLA, DEGS1, LIPA | TSHR 4249/4885THRB 3339/4885LMNA 1401/4885 |
| US-20260053760-A1 | Compositions Suitable for Use on Skin Afflicted with Eczema | CUTA, OAT, IL17A | TSHR 4561/4885THRB 3670/4885LMNA 3617/4885 |
| US-20260083659-A1 | SUNSCREEN COMPOSITIONS AND METHODS OF USE | CUTA, TYR, SUN2 | TSHR 2955/4885THRB 512/4885LMNA 4254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.